Mélissa Savard
Douglas Mental Health University Institute(CA)McGill University Health Centre(CA)Alzheimer’s Disease Neuroimaging Initiative(US)Alexion Pharmaceuticals (United States)(US)McGill University(CA)
Publications by Year
Research Areas
Dementia and Cognitive Impairment Research, Alzheimer's disease research and treatments, Functional Brain Connectivity Studies, Advanced Neuroimaging Techniques and Applications, Neuroinflammation and Neurodegeneration Mechanisms
Most-Cited Works
- → Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts(2020)1,309 cited
- → Microglial activation and tau propagate jointly across Braak stages(2021)502 cited
- → Association of Apolipoprotein E ε4 With Medial Temporal Tau Independent of Amyloid-β(2019)253 cited
- → 18F-MK-6240 PET for early and late detection of neurofibrillary tangles(2020)246 cited
- → Cerebrospinal fluid p-tau231 as an early indicator of emerging pathology in Alzheimer's disease(2022)173 cited
- → Mild behavioral impairment is associated with β‐amyloid but not tau or neurodegeneration in cognitively intact elderly individuals(2020)167 cited